van Hylckama Vlieg Johan 4
4 · Kaleido Biosciences, Inc. · Filed Sep 2, 2021
Insider Transaction Report
Form 4
van Hylckama Vlieg Johan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-01+40,000→ 40,000 totalExercise: $6.29Exp: 2031-08-31→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on September 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.